Relevant publications examining issues to do with cannabis that have been published in the last month include the following:

• Abrams, D.I., Couey, P., Shade, S.B., Kelly, M.E., & Benowitz, N.L. (2011). Cannabinoid-opioid interaction in chronic pain. Clinical Pharmacology and Therapeutics 90, 844-851.
• Agrawal, A., Scherrer, J.F., Lynskey, M.T., Sartor, C.E., Grant, J.D., Haber, J.R., Madden, P.A., Jacob, T., Bucholz, K.K., & Xian, H. (2011). Patterns of use, sequence of onsets and correlates of tobacco and cannabis. Addictive Behaviors 36, 1141-1147.
• Allsop, D.J., Norberg, M.M., Copeland, J., Fu, S., & Budney, A.J. (2011). The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress. Drug and Alcohol Dependence 119, 123-129.
• Dragt, S., Nieman, D.H., Schultze-Lutter, F., van der Meer, F., Becker, H., de Haan, L., Dingemans, P.M., Birchwood, M., Patterson, P., Salokangas, R.K., Heinimaa, M., Heinz, A., Juckel, G., Graf von Reventlow, H., French, P., Stevens, H., Ruhrmann, S., Klosterkötter, J., Linszen, D.H.; on behalf of the EPOS group. (2012). Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis. Acta Psychiatrica Scandinavica 125, 45-53.
• Gowran, A., Noonan, J. & Campbell, V.A. (2011). The multiplicity of action of cannabinoids: Implications for treating neurodegeneration. CNS Neuroscience and Therapeutics 17, 637-644.
• Hendriks, V., van der Schee, E. & Blanken, P. (2011). Treatment of adolescents with a cannabis use disorder: Main findings of a randomized controlled trial comparing multidimensional family therapy and cognitive behavioral therapy in The Netherlands. Drug and Alcohol Dependence 119, 64-71.
• King, G.R., Ernst, T., Deng, W., Stenger, A., Gonzales, R.M., Nakama, H., & Chang, L. (2011). Altered brain activation during visuomotor integration in chronic active cannabis users: Relationship to cortisol levels. Journal of Neuroscience 31, 17923-17931.
• Konings, M., Stefanis, N., Kuepper, R., de Graaf, R., Have, M.T., van Os, J., Bakoula, C., & Henquet, C. (2012). Replication in two independent population-based samples that childhood maltreatment and cannabis use synergistically impact on psychosis risk. Psychological Medicine 42, 149-159.
• Mir, A., Obafemi, A., Young, A., & Kane, C. (2011). Myocardial infarction associated with use of the synthetic cannabinoid k2. Pediatrics 128, 1622-1627.
• Oshri, A., Rogosch, F.A., Burnette, M.L., & Cicchetti, D. (2011). Developmental pathways to adolescent cannabis abuse and dependence: Child maltreatment, emerging personality, and internalizing versus externalizing psychopathology. Psychology of Addictive Behaviors 25, 634-644.
• Pulido, J., Barrio, G., Lardelli, P., Bravo, M.J., Regidor, E., & de la Fuente, L. (2011). Association between cannabis and cocaine use, traffic injuries and use of protective devices. European Journal of Public Health 21, 753-755.
• Shen, E.Y., Ali, S.F. & Meyer, J.S. (2011). Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats. Neuropharmacology 61, 1183-1192.
• Steel, R.W., Miller, J.H., Sim, D.A., & Day, D.J. (2011). Learning impairment by Δ9-tetrahydrocannabinol in adolescence is attributable to deficits in chunking. Behavioural Pharmacology 22, 837-846.
• Tait, R.J., Mackinnon, A. & Christensen, H. (2011). Cannabis use and cognitive function: 8-year trajectory in a young adult cohort. Addiction 106, 2195-2203.
• Tepe, E., Dalrymple, K. & Zimmerman, M. (2012). The impact of comorbid cannabis use disorders on the clinical presentation of social anxiety disorder. Journal of Psychiatric Research 46, 50-56.
• Uritsky, T.J., McPherson, M.L. & Pradel, F. (2011). Assessment of hospice health professionals' knowledge, views, and experience with medical marijuana. Journal of Palliative Medicine 14, 1291-1295.
• Ware, M.A. (2011). Clearing the smoke around medical marijuana. Clinical Pharmacology and Therapeutics 90, 769-771.